Global Antivirals Market Size
Pharmaceuticals

Growth Trajectory Of The Antivirals Market 2023-2032

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global antivirals market is expected to grow from $97.14 billion in 2022 to $107.84 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The global antivirals market size is expected to grow to $156.99 billion in 2027 at a CAGR of 9.8%.

North America held the largest antivirals market share, and Middle East was the fastest-growing region in 2022.

Antivirals Market Driver
Globally increasing public-private financing for life science research is predicted to propel the anti-viral medication therapy market forward. There are currently no licenced medications or vaccinations for the treatment of COVID-19 disease, although there are several vaccines and treatments in the pipeline that have yet to be approved or marketed. Governments all over the world have announced fresh grant monies for vaccination, therapy, and diagnostic studies. The Canadian government announced $214.6 million for coronavirus research in March 2020. Wellcome and the Gates Foundation have established a $125 million collaboration with MasterCard to accelerate the development of medications to treat COVID-19 infections. As a result, growing public-private investment for life science research will boost R&D, which will fuel the expansion of the COVID-19 anti-viral medication therapy market.

View More On The Antivirals Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Prominent Antivirals Market Trend
Anti-viral drug therapy companies are constantly developing through technology developments to develop pharmaceuticals to treat various viral illnesses. Vaccines for new coronaviruses are being developed by biopharmaceutical companies. Pharmaceutical technological developments include the invention of nucleic acid vaccines based on DNA and RNA that allow the human body to generate vaccination antigens. LineaRx, a subsidiary of Applied DNA Sciences, and Takis Biotech formed a joint venture in March 2020 to develop a linear DNA vaccine as a coronavirus treatment. The vaccine will be developed by the JV using DNA manufacturing technology based on Polymerase Chain Reaction (PCR). Such initiatives and actions are expected to significantly help market growth.

Antivirals Market Prominent Players
Major players in the antivirals market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca PLC., Aurobindo Pharma, Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi, Sanofi, Regeneron Pharmaceuticals, Inc., Inovio Pharmaceuticals, Inc., Novavax, Inc., and BioCryst Pharmaceuticals, Inc.

Request A Sample Of The Global Antivirals Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Key Antivirals Market Segments
The global antivirals market is segmented –
1) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug Classes
2) By Application: HIV, Hepatitis, Herpes, Influenza, and Other Applications
3) By Type: Branded, Generic

The Antivirals Global Market Report 2023  provides a comprehensive overview on the antivirals market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the antivirals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
AntiHypertensive Drugs Global Market Report 2023
Antiemetics And Antinauseants Global Market Report 2023
AntiThyroid Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model